The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,958.00
Bid: 1,951.00
Ask: 1,953.00
Change: -1.00 (-0.05%)
Spread: 2.00 (0.103%)
Open: 1,942.00
High: 1,958.00
Low: 1,938.00
Prev. Close: 1,959.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London midday: Stocks inch lower on mixed data and earnings

Wed, 23rd Apr 2014 11:37

- AB Foods jumps, ARM and Sports Direct fall- UK borrowing falls more than expected- Chinese manufacturing still in contraction- Eurozone business activity improvestechMARK 2,740.84 +0.09%FTSE 100 6,670.05 -0.18%FTSE 250 15,991.94 -0.56%UK stocks pulled back from a three-week high on Wednesday, but were trading within a narrow range as investors digested mixed economic data and a host of corporate earnings.Primark owner Associated British Foods was a stand-out performer, rising sharply after announcing plans to open its first store in the States as it rolls out the fast-growing fashion outlet overseas.Quarterly trading updates from ARM Holdings and Sports Direct, however, disappointed investors this morning with both stocks falling sharply.The FTSE 100 was down 12 points, or 0.2%, at 6,670.05 by midday, with just 27 points separating its intra-day low and high.The index gained 0.9% on Tuesday on the back of heightened M&A activity and bid speculation in the global pharmaceutical sector, rising to 6,681.76, its highest close since April 4th. In economic data today, UK public sector net borrowing slipped to £6.7bn in March, from £8.8bn the month before, according to the Office for National Statistics, well below the consensus estimate of £11bn.Purchasing managers' indices (PMIs) from across the globe were also in focus, including a private survey in China which showed that the manufacturing sector contracted for a fourth straight month in April. The PMI improved from 48 to 48.3, in line with expectations but still under the key 50-point threshold that separates growth from contraction.The Eurozone composite PMI rose from 53.1 to a 35-month high of 54 in April, ahead of expectations, as activity in both manufacturing and services increased. The manufacturing PMI in the US is also due out later on and is expected to show that growth picked up this month. Meanwhile, results from Wall Street giants Apple and Facebook after the closing bell this evening will likely be closely watched by investors.In other news, the minutes of the Monetary Policy Committee's last rate-setting meeting showed that the decision to keep monetary policy unchanged was supported by the full majority of its members.AB Foods jumps on US expansion, resultsAB Foods jumped after saying that it would open new Primark stores in north-east US. The chain, which already has stores in nine countries in Western Europe, has signed a lease for 70,000 square feet of selling space in Boston and will open the shop towards the end of 2015. Further stores are planned across the wider region through to the middle of 2016.The company also reported a 4% increase in adjusted pre-tax profits to £468m for the 24 weeks to March 1st, helped by a 26% jump in operating profits at Primark.AstraZeneca was continuing to rise on speculation that US pharmaceutical peer Pfizer could offer as much as £60bn to buy the company, representing the largest foreign takeover of a UK business on record. The stock, which rose 5% yesterday, was making solid gains this morning.Similarly, GlaxoSmithKline extended gains after yesterday unveiling a massive three-part deal with Swiss firm Novartis, under which shareholders will receive a £4bn a capital return.Chip designer ARM Holdings declined after the company's first-quarter results showed strong licensing revenues and weak royalties. Analysts at finnCap said that company remains on track to hit forecasts but it "is just not showing the growth rates to see the shares push beyond the current price-to-earnings ratio of 40".High street sporting goods retailer Sports Direct was also lower after seeing a slight slowdown in growth in the fourth quarter. The company also warned of "further uncertainty" arising from its decision to cancel a controversial bonus payout to founder Mike Ashley earlier this month.Retail-focused property group Hammerson rose after giving a confident outlook, saying that an improving UK recovery filtered through to demand in the first quarter.Antofagasta was trading firmly in the red this morning after going ex-dividend, meaning that from today new investors won't be able to obtain the company's latest payout. FTSE 100-listed peers Aggreko, BG Group, Centrica, Legal & General, Mondi, Old Mutual and Rolls-Royce were also trading without the rights to their latest dividends this morning.A number of FTSE 250 stocks were also lower after going ex-dividend, including Hikma, Drax, Kentz and Tullett Prebon.FTSE 100 - RisersAssociated British Foods (ABF) 2,962.00p +8.82%Admiral Group (ADM) 1,399.00p +2.64%AstraZeneca (AZN) 4,038.00p +1.97%Randgold Resources Ltd. (RRS) 4,683.00p +1.69%Royal Mail (RMG) 530.50p +1.63%Tesco (TSCO) 296.90p +1.54%Wolseley (WOS) 3,410.00p +1.46%Land Securities Group (LAND) 1,073.00p +1.42%Experian (EXPN) 1,121.00p +1.26%Hammerson (HMSO) 580.00p +1.05%FTSE 100 - FallersAntofagasta (ANTO) 794.50p -5.92%Centrica (CNA) 330.80p -4.09%Sports Direct International (SPD) 799.50p -3.67%Old Mutual (OML) 196.60p -3.63%Morrison (Wm) Supermarkets (MRW) 197.30p -3.33%ARM Holdings (ARM) 954.50p -2.90%Aberdeen Asset Management (ADN) 432.20p -2.61%Legal & General Group (LGEN) 207.00p -2.45%Ashtead Group (AHT) 878.50p -2.44%Standard Chartered (STAN) 1,282.00p -2.25%FTSE 250 - RisersSpirent Communications (SPT) 104.80p +8.49%Fenner (FENR) 409.40p +4.97%Merlin Entertainments (MERL) 365.30p +3.72%Centamin (DI) (CEY) 54.65p +3.31%Thomas Cook Group (TCG) 179.30p +3.28%Petra Diamonds Ltd.(DI) (PDL) 154.90p +2.79%Daejan Holdings (DJAN) 4,984.00p +1.67%SEGRO (SGRO) 349.40p +1.28%3i Group (III) 391.70p +1.27%Caledonia Investments (CLDN) 2,100.00p +1.20%FTSE 250 - FallersDrax Group (DRX) 662.00p -12.49%Tullett Prebon (TLPR) 294.40p -5.67%Imagination Technologies Group (IMG) 183.00p -4.29%Moneysupermarket.com Group (MONY) 179.00p -4.07%Balfour Beatty (BBY) 289.60p -3.40%Ocado Group (OCDO) 363.00p -2.94%Man Group (EMG) 100.30p -2.72%Bellway (BWY) 1,534.00p -2.67%International Public Partnerships Ltd. (INPP) 126.10p -2.47%Victrex plc (VCT) 1,948.00p -2.31%BC
More News
17 Jan 2022 09:01

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

Read more
17 Jan 2022 09:00

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

Read more
17 Jan 2022 07:49

LONDON MARKET PRE-OPEN: Unilever sees good fit in GSK Consumer Health

LONDON MARKET PRE-OPEN: Unilever sees good fit in GSK Consumer Health

Read more
17 Jan 2022 07:08

Hikma buys Teligent Canadian assets for $47.75m

(Sharecast News) - Hikma Pharmaceuticals on Monday said it had agreed to buy the Canadian assets of Teligent for $45.75m after the US firm filed for Chapter 11 bankruptcy last year.

Read more
10 Jan 2022 07:44

LONDON MARKET PRE-OPEN: Plus500 hails 2021 and mulls new share buyback

LONDON MARKET PRE-OPEN: Plus500 hails 2021 and mulls new share buyback

Read more
10 Jan 2022 07:24

Hikma launches new US injectables unit

(Sharecast News) - Hikma Pharmaceuticals on Monday said it was expanding its injectables business with the launch of a new outsourced sterile compounding business in the US.

Read more
21 Dec 2021 15:55

Arecor flags milestone payment from Hikma in first half of next year

(Sharecast News) - Biopharmaceutical company Arecor Therapeutics updated the market on its ongoing exclusive agreement with Hikma Pharmaceuticals to co-develop a new, ready-to-use injectable medicine on Tuesday.

Read more
9 Dec 2021 09:25

Hikma adds two biosimilars to portfolio with Gedeon Richter agreement

Hikma adds two biosimilars to portfolio with Gedeon Richter agreement

Read more
9 Dec 2021 08:32

Hikma strikes exclusive license agreement with Richter for denosumab

(Sharecast News) - Drugmaker Hikma Pharmaceuticals has entered into an exclusive license agreement with Gedeon Richter to commercialise the latter's denosumab products in the US.

Read more
4 Nov 2021 09:03

TOP NEWS: Hikma confirms 2021 guidance amid strong performance

TOP NEWS: Hikma confirms 2021 guidance amid strong performance

Read more
4 Nov 2021 07:58

Hikma reports solid trading in year to date

(Sharecast News) - Hikma Pharmaceuticals reiterated full-year guidance as the company reported solid trading across its business.

Read more
1 Nov 2021 13:52

Citi sees room for upside surprise on sales at Hikma Pharmaceuticals

(Sharecast News) - Analysts at Citi reiterated their 'buy' stance for shares of Hikma Pharmaceuticals ahead of the company's trading statement due out later in the same week.

Read more
28 Oct 2021 16:12

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
20 Oct 2021 09:51

LONDON BROKER RATINGS: BofA cuts Hammerson and upgrades Capco

LONDON BROKER RATINGS: BofA cuts Hammerson and upgrades Capco

Read more
27 Sep 2021 12:14

LONDON MARKET MIDDAY: Gains ebb; crunch time for US spending bills

LONDON MARKET MIDDAY: Gains ebb; crunch time for US spending bills

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.